Analysts think KURA stock price could increase by 145%
Dec 09, 2025, 12:25 PM
-10.78%
What does KURA do
Kura Oncology, headquartered in San Diego, focuses on developing precision medicines for cancer treatment, including small molecule candidates Ziftomenib, Tipifarnib, and KO-2806. The company went public in November 2015 and employs 142 staff.
13 analysts think KURA stock price will increase by 145.26%. The current median analyst target is $28.56 compared to a current stock price of $11.64. The lowest analysts target is $16.16 and the highest analyst target is $79.80.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.